Global Aurora Kinase C Market Growth 2025-2031

October 2025 | 76 pages | ID: G044883E82B4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Aurora Kinase C market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Aurora Kinase C is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Aurora Kinase C is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Aurora Kinase C is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Aurora Kinase C players cover AbbVie Inc, Amgen Inc, Cielo Therapeutics Inc, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Aurora Kinase C Industry Forecast” looks at past sales and reviews total world Aurora Kinase C sales in 2024, providing a comprehensive analysis by region and market sector of projected Aurora Kinase C sales for 2025 through 2031. With Aurora Kinase C sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aurora Kinase C industry.

This Insight Report provides a comprehensive analysis of the global Aurora Kinase C landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aurora Kinase C portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aurora Kinase C market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aurora Kinase C and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aurora Kinase C.

This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase C market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • AMG-900
  • Danusertib
  • Ilorasertib
  • NMI-900
  • SAR-156497
  • Others
Segmentation by Application:
  • Solid Tumor
  • Non-Small Cell Lung Cancer
  • Acute Lymphocytic Leukemia
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • AbbVie Inc
  • Amgen Inc
  • Cielo Therapeutics Inc
  • Sanofi
Key Questions Addressed in this Report

What is the 10-year outlook for the global Aurora Kinase C market?
What factors are driving Aurora Kinase C market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aurora Kinase C market opportunities vary by end market size?
How does Aurora Kinase C break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Banking Smart Cards Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Banking Smart Cards by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Banking Smart Cards by Country/Region, 2020, 2024 & 2031
2.2 Banking Smart Cards Segment by Type
  2.2.1 Magnetic Stripe Card
  2.2.2 Chip Card
  2.2.3 Dual Interface Card
  2.2.4 Others
2.3 Banking Smart Cards Sales by Type
  2.3.1 Global Banking Smart Cards Sales Market Share by Type (2020-2025)
  2.3.2 Global Banking Smart Cards Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Banking Smart Cards Sale Price by Type (2020-2025)
2.4 Banking Smart Cards Segment by Application
  2.4.1 Commercial
  2.4.2 Personal
  2.4.3 Others
2.5 Banking Smart Cards Sales by Application
  2.5.1 Global Banking Smart Cards Sale Market Share by Application (2020-2025)
  2.5.2 Global Banking Smart Cards Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Banking Smart Cards Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Banking Smart Cards Breakdown Data by Company
  3.1.1 Global Banking Smart Cards Annual Sales by Company (2020-2025)
  3.1.2 Global Banking Smart Cards Sales Market Share by Company (2020-2025)
3.2 Global Banking Smart Cards Annual Revenue by Company (2020-2025)
  3.2.1 Global Banking Smart Cards Revenue by Company (2020-2025)
  3.2.2 Global Banking Smart Cards Revenue Market Share by Company (2020-2025)
3.3 Global Banking Smart Cards Sale Price by Company
3.4 Key Manufacturers Banking Smart Cards Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Banking Smart Cards Product Location Distribution
  3.4.2 Players Banking Smart Cards Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BANKING SMART CARDS BY GEOGRAPHIC REGION

4.1 World Historic Banking Smart Cards Market Size by Geographic Region (2020-2025)
  4.1.1 Global Banking Smart Cards Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Banking Smart Cards Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Banking Smart Cards Market Size by Country/Region (2020-2025)
  4.2.1 Global Banking Smart Cards Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Banking Smart Cards Annual Revenue by Country/Region (2020-2025)
4.3 Americas Banking Smart Cards Sales Growth
4.4 APAC Banking Smart Cards Sales Growth
4.5 Europe Banking Smart Cards Sales Growth
4.6 Middle East & Africa Banking Smart Cards Sales Growth

5 AMERICAS

5.1 Americas Banking Smart Cards Sales by Country
  5.1.1 Americas Banking Smart Cards Sales by Country (2020-2025)
  5.1.2 Americas Banking Smart Cards Revenue by Country (2020-2025)
5.2 Americas Banking Smart Cards Sales by Type (2020-2025)
5.3 Americas Banking Smart Cards Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Banking Smart Cards Sales by Region
  6.1.1 APAC Banking Smart Cards Sales by Region (2020-2025)
  6.1.2 APAC Banking Smart Cards Revenue by Region (2020-2025)
6.2 APAC Banking Smart Cards Sales by Type (2020-2025)
6.3 APAC Banking Smart Cards Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Banking Smart Cards by Country
  7.1.1 Europe Banking Smart Cards Sales by Country (2020-2025)
  7.1.2 Europe Banking Smart Cards Revenue by Country (2020-2025)
7.2 Europe Banking Smart Cards Sales by Type (2020-2025)
7.3 Europe Banking Smart Cards Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Banking Smart Cards by Country
  8.1.1 Middle East & Africa Banking Smart Cards Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Banking Smart Cards Revenue by Country (2020-2025)
8.2 Middle East & Africa Banking Smart Cards Sales by Type (2020-2025)
8.3 Middle East & Africa Banking Smart Cards Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Banking Smart Cards
10.3 Manufacturing Process Analysis of Banking Smart Cards
10.4 Industry Chain Structure of Banking Smart Cards

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Banking Smart Cards Distributors
11.3 Banking Smart Cards Customer

12 WORLD FORECAST REVIEW FOR BANKING SMART CARDS BY GEOGRAPHIC REGION

12.1 Global Banking Smart Cards Market Size Forecast by Region
  12.1.1 Global Banking Smart Cards Forecast by Region (2026-2031)
  12.1.2 Global Banking Smart Cards Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Banking Smart Cards Forecast by Type (2026-2031)
12.7 Global Banking Smart Cards Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Gemalto
  13.1.1 Gemalto Company Information
  13.1.2 Gemalto Banking Smart Cards Product Portfolios and Specifications
  13.1.3 Gemalto Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Gemalto Main Business Overview
  13.1.5 Gemalto Latest Developments
13.2 Giesecke & Devrient
  13.2.1 Giesecke & Devrient Company Information
  13.2.2 Giesecke & Devrient Banking Smart Cards Product Portfolios and Specifications
  13.2.3 Giesecke & Devrient Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Giesecke & Devrient Main Business Overview
  13.2.5 Giesecke & Devrient Latest Developments
13.3 Morpho
  13.3.1 Morpho Company Information
  13.3.2 Morpho Banking Smart Cards Product Portfolios and Specifications
  13.3.3 Morpho Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Morpho Main Business Overview
  13.3.5 Morpho Latest Developments
13.4 Oberthur Technologies
  13.4.1 Oberthur Technologies Company Information
  13.4.2 Oberthur Technologies Banking Smart Cards Product Portfolios and Specifications
  13.4.3 Oberthur Technologies Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Oberthur Technologies Main Business Overview
  13.4.5 Oberthur Technologies Latest Developments
13.5 American Express
  13.5.1 American Express Company Information
  13.5.2 American Express Banking Smart Cards Product Portfolios and Specifications
  13.5.3 American Express Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 American Express Main Business Overview
  13.5.5 American Express Latest Developments
13.6 ARM
  13.6.1 ARM Company Information
  13.6.2 ARM Banking Smart Cards Product Portfolios and Specifications
  13.6.3 ARM Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 ARM Main Business Overview
  13.6.5 ARM Latest Developments
13.7 Bell ID
  13.7.1 Bell ID Company Information
  13.7.2 Bell ID Banking Smart Cards Product Portfolios and Specifications
  13.7.3 Bell ID Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Bell ID Main Business Overview
  13.7.5 Bell ID Latest Developments
13.8 CardLogix
  13.8.1 CardLogix Company Information
  13.8.2 CardLogix Banking Smart Cards Product Portfolios and Specifications
  13.8.3 CardLogix Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 CardLogix Main Business Overview
  13.8.5 CardLogix Latest Developments
13.9 DataCard
  13.9.1 DataCard Company Information
  13.9.2 DataCard Banking Smart Cards Product Portfolios and Specifications
  13.9.3 DataCard Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 DataCard Main Business Overview
  13.9.5 DataCard Latest Developments
13.10 HID Global
  13.10.1 HID Global Company Information
  13.10.2 HID Global Banking Smart Cards Product Portfolios and Specifications
  13.10.3 HID Global Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 HID Global Main Business Overview
  13.10.5 HID Global Latest Developments
13.11 Infineon Technologies
  13.11.1 Infineon Technologies Company Information
  13.11.2 Infineon Technologies Banking Smart Cards Product Portfolios and Specifications
  13.11.3 Infineon Technologies Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Infineon Technologies Main Business Overview
  13.11.5 Infineon Technologies Latest Developments
13.12 MasterCard
  13.12.1 MasterCard Company Information
  13.12.2 MasterCard Banking Smart Cards Product Portfolios and Specifications
  13.12.3 MasterCard Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 MasterCard Main Business Overview
  13.12.5 MasterCard Latest Developments
13.13 Smart Card IT Solutions
  13.13.1 Smart Card IT Solutions Company Information
  13.13.2 Smart Card IT Solutions Banking Smart Cards Product Portfolios and Specifications
  13.13.3 Smart Card IT Solutions Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Smart Card IT Solutions Main Business Overview
  13.13.5 Smart Card IT Solutions Latest Developments
13.14 Visa
  13.14.1 Visa Company Information
  13.14.2 Visa Banking Smart Cards Product Portfolios and Specifications
  13.14.3 Visa Banking Smart Cards Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Visa Main Business Overview
  13.14.5 Visa Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Aurora Kinase C Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aurora Kinase C Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AMG-900
Table 4. Major Players of Danusertib
Table 5. Major Players of Ilorasertib
Table 6. Major Players of NMI-900
Table 7. Major Players of SAR-156497
Table 8. Major Players of Others
Table 9. Global Aurora Kinase C Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Aurora Kinase C Sales Market Share by Type (2020-2025)
Table 11. Global Aurora Kinase C Revenue by Type (2020-2025) & ($ million)
Table 12. Global Aurora Kinase C Revenue Market Share by Type (2020-2025)
Table 13. Global Aurora Kinase C Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Aurora Kinase C Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Aurora Kinase C Sale Market Share by Application (2020-2025)
Table 16. Global Aurora Kinase C Revenue by Application (2020-2025) & ($ million)
Table 17. Global Aurora Kinase C Revenue Market Share by Application (2020-2025)
Table 18. Global Aurora Kinase C Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Aurora Kinase C Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Aurora Kinase C Sales Market Share by Company (2020-2025)
Table 21. Global Aurora Kinase C Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Aurora Kinase C Revenue Market Share by Company (2020-2025)
Table 23. Global Aurora Kinase C Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Aurora Kinase C Producing Area Distribution and Sales Area
Table 25. Players Aurora Kinase C Products Offered
Table 26. Aurora Kinase C Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Aurora Kinase C Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Aurora Kinase C Sales Market Share Geographic Region (2020-2025)
Table 31. Global Aurora Kinase C Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Aurora Kinase C Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Aurora Kinase C Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Aurora Kinase C Sales Market Share by Country/Region (2020-2025)
Table 35. Global Aurora Kinase C Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Aurora Kinase C Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Aurora Kinase C Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Aurora Kinase C Sales Market Share by Country (2020-2025)
Table 39. Americas Aurora Kinase C Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Aurora Kinase C Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Aurora Kinase C Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Aurora Kinase C Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Aurora Kinase C Sales Market Share by Region (2020-2025)
Table 44. APAC Aurora Kinase C Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Aurora Kinase C Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Aurora Kinase C Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Aurora Kinase C Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Aurora Kinase C Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Aurora Kinase C Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Aurora Kinase C Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Aurora Kinase C Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Aurora Kinase C Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Aurora Kinase C Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Aurora Kinase C Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Aurora Kinase C
Table 56. Key Market Challenges & Risks of Aurora Kinase C
Table 57. Key Industry Trends of Aurora Kinase C
Table 58. Aurora Kinase C Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Aurora Kinase C Distributors List
Table 61. Aurora Kinase C Customer List
Table 62. Global Aurora Kinase C Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Aurora Kinase C Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Aurora Kinase C Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Aurora Kinase C Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Aurora Kinase C Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Aurora Kinase C Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Aurora Kinase C Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Aurora Kinase C Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Aurora Kinase C Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Aurora Kinase C Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Aurora Kinase C Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Aurora Kinase C Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Aurora Kinase C Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Aurora Kinase C Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. AbbVie Inc Basic Information, Aurora Kinase C Manufacturing Base, Sales Area and Its Competitors
Table 77. AbbVie Inc Aurora Kinase C Product Portfolios and Specifications
Table 78. AbbVie Inc Aurora Kinase C Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. AbbVie Inc Main Business
Table 80. AbbVie Inc Latest Developments
Table 81. Amgen Inc Basic Information, Aurora Kinase C Manufacturing Base, Sales Area and Its Competitors
Table 82. Amgen Inc Aurora Kinase C Product Portfolios and Specifications
Table 83. Amgen Inc Aurora Kinase C Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Amgen Inc Main Business
Table 85. Amgen Inc Latest Developments
Table 86. Cielo Therapeutics Inc Basic Information, Aurora Kinase C Manufacturing Base, Sales Area and Its Competitors
Table 87. Cielo Therapeutics Inc Aurora Kinase C Product Portfolios and Specifications
Table 88. Cielo Therapeutics Inc Aurora Kinase C Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Cielo Therapeutics Inc Main Business
Table 90. Cielo Therapeutics Inc Latest Developments
Table 91. Sanofi Basic Information, Aurora Kinase C Manufacturing Base, Sales Area and Its Competitors
Table 92. Sanofi Aurora Kinase C Product Portfolios and Specifications
Table 93. Sanofi Aurora Kinase C Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Sanofi Main Business
Table 95. Sanofi Latest Developments

LIST OF FIGURES

Figure 1. Picture of Aurora Kinase C
Figure 2. Aurora Kinase C Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aurora Kinase C Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Aurora Kinase C Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aurora Kinase C Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aurora Kinase C Sales Market Share by Country/Region (2024)
Figure 10. Aurora Kinase C Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of AMG-900
Figure 12. Product Picture of Danusertib
Figure 13. Product Picture of Ilorasertib
Figure 14. Product Picture of NMI-900
Figure 15. Product Picture of SAR-156497
Figure 16. Product Picture of Others
Figure 17. Global Aurora Kinase C Sales Market Share by Type in 2025
Figure 18. Global Aurora Kinase C Revenue Market Share by Type (2020-2025)
Figure 19. Aurora Kinase C Consumed in Solid Tumor
Figure 20. Global Aurora Kinase C Market: Solid Tumor (2020-2025) & (K Pcs)
Figure 21. Aurora Kinase C Consumed in Non-Small Cell Lung Cancer
Figure 22. Global Aurora Kinase C Market: Non-Small Cell Lung Cancer (2020-2025) & (K Pcs)
Figure 23. Aurora Kinase C Consumed in Acute Lymphocytic Leukemia
Figure 24. Global Aurora Kinase C Market: Acute Lymphocytic Leukemia (2020-2025) & (K Pcs)
Figure 25. Aurora Kinase C Consumed in Others
Figure 26. Global Aurora Kinase C Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Aurora Kinase C Sale Market Share by Application (2024)
Figure 28. Global Aurora Kinase C Revenue Market Share by Application in 2025
Figure 29. Aurora Kinase C Sales by Company in 2025 (K Pcs)
Figure 30. Global Aurora Kinase C Sales Market Share by Company in 2025
Figure 31. Aurora Kinase C Revenue by Company in 2025 ($ millions)
Figure 32. Global Aurora Kinase C Revenue Market Share by Company in 2025
Figure 33. Global Aurora Kinase C Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Aurora Kinase C Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Aurora Kinase C Sales 2020-2025 (K Pcs)
Figure 36. Americas Aurora Kinase C Revenue 2020-2025 ($ millions)
Figure 37. APAC Aurora Kinase C Sales 2020-2025 (K Pcs)
Figure 38. APAC Aurora Kinase C Revenue 2020-2025 ($ millions)
Figure 39. Europe Aurora Kinase C Sales 2020-2025 (K Pcs)
Figure 40. Europe Aurora Kinase C Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Aurora Kinase C Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Aurora Kinase C Revenue 2020-2025 ($ millions)
Figure 43. Americas Aurora Kinase C Sales Market Share by Country in 2025
Figure 44. Americas Aurora Kinase C Revenue Market Share by Country (2020-2025)
Figure 45. Americas Aurora Kinase C Sales Market Share by Type (2020-2025)
Figure 46. Americas Aurora Kinase C Sales Market Share by Application (2020-2025)
Figure 47. United States Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Aurora Kinase C Sales Market Share by Region in 2025
Figure 52. APAC Aurora Kinase C Revenue Market Share by Region (2020-2025)
Figure 53. APAC Aurora Kinase C Sales Market Share by Type (2020-2025)
Figure 54. APAC Aurora Kinase C Sales Market Share by Application (2020-2025)
Figure 55. China Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 59. India Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Aurora Kinase C Sales Market Share by Country in 2025
Figure 63. Europe Aurora Kinase C Revenue Market Share by Country (2020-2025)
Figure 64. Europe Aurora Kinase C Sales Market Share by Type (2020-2025)
Figure 65. Europe Aurora Kinase C Sales Market Share by Application (2020-2025)
Figure 66. Germany Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 67. France Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Aurora Kinase C Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Aurora Kinase C Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Aurora Kinase C Sales Market Share by Application (2020-2025)
Figure 74. Egypt Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Aurora Kinase C Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Aurora Kinase C in 2025
Figure 80. Manufacturing Process Analysis of Aurora Kinase C
Figure 81. Industry Chain Structure of Aurora Kinase C
Figure 82. Channels of Distribution
Figure 83. Global Aurora Kinase C Sales Market Forecast by Region (2026-2031)
Figure 84. Global Aurora Kinase C Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Aurora Kinase C Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Aurora Kinase C Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Aurora Kinase C Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Aurora Kinase C Revenue Market Share Forecast by Application (2026-2031)